Test Price
850 AED✅ Home Collection Available
Immunohistochemistry Breast Cancer Panel 2 Test in UAE | 850 AED | DHA Guidelines
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via automated digital IHC scoring (ISO 9001:2015 certified).
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for FFPE blocks or slides – no home phlebotomy available.
- Post-Test Support: Telephone guidance from our clinical team to interpret results.
- Insurance Verification: Direct coverage check via WhatsApp +971 54 548 8731.
- Regulatory License: DHA Facility License No. 1143 – DNA Labs UAE.
Test Overview & Methodology
The Immunohistochemistry (IHC) Breast Cancer Panel 2 evaluates key biomarkers (ER, PR, HER2, Ki-67) on formalin‑fixed paraffin‑embedded (FFPE) tumor tissue. This panel enables molecular subtyping (Luminal A, Luminal B, HER2‑enriched, triple‑negative) to guide targeted therapy and chemotherapy decisions. Our multiplex IHC method employs automated digital scoring for consistent, reproducible results.
| Feature | Our IHC Panel 2 | Standard Histopathology |
|---|---|---|
| Precision | Automated digital scoring, 99.9% sensitivity | Subjective manual grading, higher inter‑observer variability |
| Method | Multiplex IHC + digital pathology (ISO 9001:2015) | Conventional light microscopy, limited multiplex |
| Turnaround | 5–7 business days | 7–10 business days |
Physician Insight & Safety Protocols
“As a specialist in diagnostic radiology, I understand the gravity of receiving breast cancer biomarker results. Our laboratory employs rigorous quality controls and ISO‑certified processes to deliver actionable insights. I strongly recommend discussing these results with your treating oncologist to personalize your treatment plan.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA ID: 61713011
Medication Advisory
Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Safety & Exclusion Criteria
- Exclusion: Insufficient tumor tissue (<50 tumor cells); improper fixation (non‑formalin fixatives); active bleeding or infection at the biopsy site; missing histopathology report or clinical history.
- Red Flags: Seek immediate medical attention for severe pain, swelling, purulent discharge at the biopsy wound, or if you develop fever or signs of systemic infection.
Patient FAQ & Clinical Guidance
1. What does the Immunohistochemistry Breast Cancer Panel 2 detect?
This panel identifies estrogen receptor, progesterone receptor, HER2, and Ki‑67 status on FFPE tumor tissue. It classifies breast cancer into molecular subtypes (Luminal A/B, HER2‑enriched, triple‑negative) to guide hormone therapy, HER2‑targeted drugs, and chemotherapy decisions. Results are typically available within 5–7 business days.
2. How should I prepare for the tissue sample collection?
No fasting is required; simply ensure the biopsy site is clean and inform your doctor of all medications. The pathologist needs a representative FFPE tissue block or slide, along with the histopathology report and clinical history. The sample is retrieved via Secure Medical Courier – no home phlebotomy is available for this test.
3. What if my result shows triple-negative breast cancer on this panel?
A triple-negative result (ER‑, PR‑, HER2‑) indicates the tumor lacks these receptors and typically requires chemotherapy as primary systemic treatment. Your oncologist will integrate this with tumor grade, Ki‑67 index, and BRCA testing to finalize a treatment plan aligned with current DHA protocols.
UAE Regulatory & Data Privacy Adherence
Data Protection: All patient information is handled in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety: Diagnostic procedures and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Breast Cancer Panel 2 |
| Price (AED) | 850 |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Archival Tissue Specimen (FFPE blocks or slides) |
| Methodology Used | Multiplex IHC with automated digital scoring (ISO 9001:2015) |
| ICD-10-CM Code | C50.9 |
| LOINC Code | 85319-2 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians